MedTrace Logo

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

NCT03075969 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 337

Last updated 2019-03-21

No results posted yet for this study

Summary

The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.

Conditions

  • Chronic Myeloid Leukemia

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Fabio Efficace, PhD · GIMEMA Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-03
Primary Completion
2019-03-16
Completion
2019-12-31

Countries

  • United States
  • Austria
  • Brazil
  • China
  • Germany
  • Iraq
  • Italy
  • Malaysia
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03075969 on ClinicalTrials.gov